APOE and Alzheimer disease: To determine how novel factors interacted with the most significant AD risk factor, APOE ɛ4, we isolated the subset of individuals who were positive for a novel factor and had undergone APOE ɛ4 testing, stratifying by APOE ɛ4 positive and negative status.